Loading clinical trials...
Loading clinical trials...
A First-in-Human Phase 1/2 Study of ABCL635 in Healthy Participants and in Postmenopausal Women With Moderate-to-Severe Vasomotor Symptoms
Conditions
Interventions
ABCL635
Placebo
Locations
12
Canada
CaRe Clinics
Calgary, Alberta, Canada
CaRe Clinics
Red Deer, Alberta, Canada
Mount Saint Joseph Hospital Clinical Trials Phase 1 Unit
Vancouver, British Columbia, Canada
Centricity Research
Toronto, Ontario, Canada
Centricity Research
Toronto, Ontario, Canada
Alpha Recherche Clinique
Lévis, Quebec, Canada
Start Date
June 23, 2025
Primary Completion Date
February 1, 2027
Completion Date
February 1, 2027
Last Updated
April 22, 2026
NCT00104325
NCT01399385
NCT03807401
NCT07499050
NCT05196061
NCT05774834
Lead Sponsor
AbCellera Biologics Inc.
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions